Monograph

Subsidy Information and Financing Scheme

Drug Guidance for Subsidy

18/01/2021 Golimumab for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis

The Ministry of Health’s Drug Advisory Committee has recommended:

Golimumab 50 mg/0.5 ml and...

Post Marketing Information

General Availability in Public Healthcare Institution
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

List of monographs containing this active ingredient

Golimumab [Simponi]

Monograph

Golimumab (Simponi) Prefilled Syringe 50 mg/0.5 mL, 100 mg/mL

MAFGolimumab (Simponi) Prefilled Syringe 50 mg/0.5 mL, 100 mg/mL

List of monographs containing this active ingredient